Your browser doesn't support javascript.
loading
Oral 5-azacytidine and romidepsin exhibit marked activity in patients with PTCL: a multicenter phase 1 study.
O'Connor, Owen A; Falchi, Lorenzo; Lue, Jennifer K; Marchi, Enrica; Kinahan, Cristina; Sawas, Ahmed; Deng, Changchun; Montanari, Francesca; Amengual, Jennifer E; Kim, Hye A; Rada, Aishling M; Khan, Karen; Jacob, Alice T; Malanga, Michelle; Francescone, Mark M; Nandakumar, Renu; Soderquist, Craig R; Park, David C; Bhagat, Govind; Cheng, Bin; Risueño, Alberto; Menezes, Daniel; Shustov, Andrei R; Sokol, Lubomir; Scotto, Luigi.
Affiliation
  • O'Connor OA; Center for Lymphoid Malignancies, Department of Medicine.
  • Falchi L; Center for Lymphoid Malignancies, Department of Medicine.
  • Lue JK; Center for Lymphoid Malignancies, Department of Medicine.
  • Marchi E; Center for Lymphoid Malignancies, Department of Medicine.
  • Kinahan C; Center for Lymphoid Malignancies, Department of Medicine.
  • Sawas A; Center for Lymphoid Malignancies, Department of Medicine.
  • Deng C; Center for Lymphoid Malignancies, Department of Medicine.
  • Montanari F; Center for Lymphoid Malignancies, Department of Medicine.
  • Amengual JE; Center for Lymphoid Malignancies, Department of Medicine.
  • Kim HA; Center for Lymphoid Malignancies, Department of Medicine.
  • Rada AM; Center for Lymphoid Malignancies, Department of Medicine.
  • Khan K; Center for Lymphoid Malignancies, Department of Medicine.
  • Jacob AT; Center for Lymphoid Malignancies, Department of Medicine.
  • Malanga M; Center for Lymphoid Malignancies, Department of Medicine.
  • Francescone MM; Department of Radiology.
  • Nandakumar R; Department of Pathology and Cell Biology, and.
  • Soderquist CR; Department of Pathology and Cell Biology, and.
  • Park DC; Department of Pathology and Cell Biology, and.
  • Bhagat G; Department of Pathology and Cell Biology, and.
  • Cheng B; Department of Statistics, Mailman School of Public Health, College of Physicians and Surgeons, Columbia University Medical Center, New York, NY.
  • Risueño A; Celgene Institute for Translational Research Europe, Seville, Spain.
  • Menezes D; Translational Development, Celgene Corporation, San Francisco, CA.
  • Shustov AR; Department of Medicine, University of Washington School of Medicine, Seattle, WA; and.
  • Sokol L; Department of Malignant Hematology, Moffitt Cancer Center, University of South Florida, Tampa, FL.
  • Scotto L; Center for Lymphoid Malignancies, Department of Medicine.
Blood ; 134(17): 1395-1405, 2019 10 24.
Article in En | MEDLINE | ID: mdl-31471376
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, T-Cell / Depsipeptides / Antibiotics, Antineoplastic Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2019 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, T-Cell / Depsipeptides / Antibiotics, Antineoplastic Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2019 Type: Article